Studies in both IBD patients and mouse models have shown a rise in intestinal mucosal macrophages, which, through the NF‐κB pathway, significantly increase the production of pro‐inflammatory cytokines including TNF‐α, IL‐6, IL‐1β, and NO (Guan 2019). The gene discussed is NFKB1; the disease is inflammatory bowel disease.